Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain

被引:15
作者
Siegel, Donald A. [1 ]
Davies, Peter [1 ]
Dobrenis, Kostantin [1 ]
Huang, May [1 ]
机构
[1] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
关键词
Alzheimer's disease; neuritic plaques; Parkinson's disease; tomoregulin-2;
D O I
10.1111/j.1471-4159.2006.03801.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tomoregulin (TR)2 is a transmembrane protein predominantly expressed in brain. It has a unique extracellular domain, containing epidermal growth factor-like and follistatin-like modules. The ectodomain is released from the cell surface, and thought to function as a neurotrophic factor and dendritogenic agent. During CNS development and in the neuronal storage disease GM2 gangliosidosis, which is characterized by ectopic dendrites, the TR2 ectodomain is present in neuronal nuclei where it may function in dendrite initiation. Data presented here demonstrate that TR2 is found extensively in Alzheimer's disease (AD) plaques. Confocal microscopy shows that TR2 is present throughout plaques. Interestingly, TR2 is absent from plaques in the presenilin-1/amyloid precursor protein mouse model of AD. From these data, and what is known about TR2, it is hypothesized that TR2 may participate in amyloid plaque formation and contribute to the pathogenesis of AD. The human TR2 gene is located on chromosome 2q32.3, near a locus linked to Parkinson's disease. TR2 is reported to be a trophic factor for dopaminergic mesencephalic neurons.
引用
收藏
页码:34 / 44
页数:11
相关论文
共 47 条
[1]   Localization and cell association of C1q in Alzheimer's disease brain [J].
Afagh, A ;
Cummings, BJ ;
Cribbs, DH ;
Cotman, CW ;
Tenner, AJ .
EXPERIMENTAL NEUROLOGY, 1996, 138 (01) :22-32
[2]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[3]   TGF-β1, regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line:: mRNA stabilization [J].
Amara, FM ;
Junaid, A ;
Clough, RR ;
Liang, BH .
MOLECULAR BRAIN RESEARCH, 1999, 71 (01) :42-49
[4]   GENERATION OF AMYLOIDOGENIC C-TERMINAL FRAGMENTS DURING RAPID AXONAL-TRANSPORT IN-VIVO OF BETA-AMYLOID PRECURSOR PROTEIN IN THE OPTIC-NERVE [J].
AMARATUNGA, A ;
FINE, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) :17268-17272
[5]   DEFINED NEUROFILAMENT, TAU-AMYLOID AND BETA-AMYLOID PRECURSOR PROTEIN EPITOPES DISTINGUISH ALZHEIMER FROM NON-ALZHEIMER SENILE PLAQUES [J].
ARAI, H ;
LEE, VMY ;
OTVOS, L ;
GREENBERG, BD ;
LOWERY, DE ;
SHARMA, SK ;
SCHMIDT, ML ;
TROJANOWSKI, JQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2249-2253
[6]   Immunological aspects of microglia: relevance to Alzheimer's disease [J].
Benveniste, EN ;
Nguyen, VT ;
O'Keefe, GM .
NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (5-6) :381-391
[7]   Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice [J].
Brendza, RP ;
Bacskai, BJ ;
Cirrito, JR ;
Simmons, KA ;
Skoch, JM ;
Klunk, WE ;
Mathis, CA ;
Bales, KR ;
Paul, SM ;
Hyman, BT ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :428-433
[8]   Transcriptional activation and increase in expression of Alzheimer's β-amyloid precursor protein gene is mediated by TGF-β in normal human astrocytes [J].
Burton, T ;
Liang, BH ;
Dibrov, A ;
Amara, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (03) :702-712
[9]   Cytokines in neuroinflammation and Alzheimer's disease [J].
Cacquevel, M ;
Lebeurrier, N ;
Chéenne, S ;
Vivien, D .
CURRENT DRUG TARGETS, 2004, 5 (06) :529-534
[10]   Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum [J].
Campion, D ;
Dumanchin, C ;
Hannequin, D ;
Dubois, B ;
Belliard, S ;
Puel, M ;
Thomas-Anterion, C ;
Michon, A ;
Martin, C ;
Charbonnier, F ;
Raux, G ;
Camuzat, A ;
Penet, C ;
Mesnage, V ;
Martinez, M ;
Clerget-Darpoux, F ;
Brice, A ;
Frebourg, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :664-670